Note: journal article by paid subscription
Commentary
CA 125: Value or addiction?
|
Patricia A. Goldman, BA * |
President Emerita, Ovarian Cancer National Alliance, Washington, DC |
|
*Correspondence to Patricia A. Goldman, Ovarian Cancer National Alliance, 910 17th Street, NW, Suite 1190, Washington, DC 20006; Fax: (202) 331-2292
The author challenges a recent study indicating that there is no apparent benefit in routinely measuring cancer antigen 125 (CA 125) in the follow-up of women with ovarian cancer. |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.